Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gi Beom Kim

Showing results (251-260 of 260) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 260 results.
Journal of Human Genetics|September 1, 2017
A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki diseaseJae-Jung Kim, Sin Weon Yun, Jeong Jin Yu, et al.
Plos One|September 9, 2017
Male-specific association of the FCGR2A His167Arg polymorphism with Kawasaki diseaseYoung-Chang Kwon, Jae-Jung Kim, Sin Weon Yun, et al.
International Journal of Heart Failure|February 6, 2025
Palliative Care and Hospice for Heart Failure Patients: Position Statement From the Korean Society of Heart FailureSeung-Mok Lee, Hae-Young Lee, Shin Hye Yoo, et al.
The American Journal of Cardiology|November 2, 2023
The Effect of Udenafil on Heart Rate and Blood Pressure in Adolescents With the Fontan CirculationJonathan B Edelson, Victor Zak, David Goldberg, et al.
Circulation. Cardiovascular Imaging|November 15, 2022
Impact of Udenafil on Echocardiographic Indices of Single Ventricle Size and Function in FUEL Study ParticipantsMichael V Di Maria, David J Goldberg, Victor Zak, et al.
Circulation|September 25, 2024
Sacubitril/Valsartan in Pediatric Heart Failure (PANORAMA-HF): A Randomized, Multicenter, Double-Blind TrialRobert Shaddy, Michael Burch, Paul F Kantor, et al.
Journal of the American Heart Association|August 12, 2025
Revisiting the Effect of Udenafil on Exercise Performance in Patients With Fontan Circulation: Results of a Post Hoc Analysis of the FUEL TrialDavid J Goldberg, Victor Zak, Chenwei Hu, et al.
Pediatric Cardiology|June 29, 2023
The Fontan Udenafil Exercise Longitudinal Trial: Subgroup AnalysisDavid J Goldberg, Chenwei Hu, Adam M Lubert, et al.
Paediatrics & Child Health|December 1, 2025
The landscape of inter-institutional and multinational collaborations in Kawasaki diseaseRocio Gutierrez Rojas, Fabiola Breault, Raed Alzyoud, et al.
Circulation|November 19, 2019
Results of the FUEL TrialDavid J Goldberg, Victor Zak, Bryan H Goldstein, et al.
Pageof 26

Showing results (251-260 of 260) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 260 results.
Journal of Human Genetics|September 1, 2017
A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki diseaseJae-Jung Kim, Sin Weon Yun, Jeong Jin Yu, et al.
Plos One|September 9, 2017
Male-specific association of the FCGR2A His167Arg polymorphism with Kawasaki diseaseYoung-Chang Kwon, Jae-Jung Kim, Sin Weon Yun, et al.
International Journal of Heart Failure|February 6, 2025
Palliative Care and Hospice for Heart Failure Patients: Position Statement From the Korean Society of Heart FailureSeung-Mok Lee, Hae-Young Lee, Shin Hye Yoo, et al.
The American Journal of Cardiology|November 2, 2023
The Effect of Udenafil on Heart Rate and Blood Pressure in Adolescents With the Fontan CirculationJonathan B Edelson, Victor Zak, David Goldberg, et al.
Circulation. Cardiovascular Imaging|November 15, 2022
Impact of Udenafil on Echocardiographic Indices of Single Ventricle Size and Function in FUEL Study ParticipantsMichael V Di Maria, David J Goldberg, Victor Zak, et al.
Circulation|September 25, 2024
Sacubitril/Valsartan in Pediatric Heart Failure (PANORAMA-HF): A Randomized, Multicenter, Double-Blind TrialRobert Shaddy, Michael Burch, Paul F Kantor, et al.
Journal of the American Heart Association|August 12, 2025
Revisiting the Effect of Udenafil on Exercise Performance in Patients With Fontan Circulation: Results of a Post Hoc Analysis of the FUEL TrialDavid J Goldberg, Victor Zak, Chenwei Hu, et al.
Pediatric Cardiology|June 29, 2023
The Fontan Udenafil Exercise Longitudinal Trial: Subgroup AnalysisDavid J Goldberg, Chenwei Hu, Adam M Lubert, et al.
Paediatrics & Child Health|December 1, 2025
The landscape of inter-institutional and multinational collaborations in Kawasaki diseaseRocio Gutierrez Rojas, Fabiola Breault, Raed Alzyoud, et al.
Circulation|November 19, 2019
Results of the FUEL TrialDavid J Goldberg, Victor Zak, Bryan H Goldstein, et al.
Pageof 26